Nurix Therapeutics (NRIX) Q2 2023 Earnings

13JulConfirmed
Oct 22
Q4 2022
Q1 2023
Q2 2023
-0.98
-0.8
-0.63
-0.45

Details

Expected EPS
-0.56
Actual EPS
-0.45
Surprise EPS
0.11
Surprise Percent
+19.64%

Description

Nurix Therapeutics (NRIX) has reported earnings of -0.45 per share for Q2 2023.

0 Comments

Share your thoughts